Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17091617rdf:typepubmed:Citationlld:pubmed
pubmed-article:17091617lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:17091617lifeskim:mentionsumls-concept:C0030567lld:lifeskim
pubmed-article:17091617lifeskim:mentionsumls-concept:C0034394lld:lifeskim
pubmed-article:17091617lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:17091617lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:17091617lifeskim:mentionsumls-concept:C0038951lld:lifeskim
pubmed-article:17091617lifeskim:mentionsumls-concept:C1705994lld:lifeskim
pubmed-article:17091617lifeskim:mentionsumls-concept:C1513492lld:lifeskim
pubmed-article:17091617pubmed:issue3lld:pubmed
pubmed-article:17091617pubmed:dateCreated2006-11-9lld:pubmed
pubmed-article:17091617pubmed:abstractTextIn this report the usefulness of a dedicated questionnaire to detect end-of-dose wearing-off (EODWO) fluctuations in PD was studied. One hundred and sixty patients were administered an 18-item questionnaire encompassing both motor and non-motor phenomena. One hundred and eight (86%) reported EODWO, defined as the occurrence of at least one symptom improving by drug intake. Motor phenomena were significantly more frequent and non-motor phenomena never occurred in isolation. This questionnaire was deemed useful by most participants.lld:pubmed
pubmed-article:17091617pubmed:languageenglld:pubmed
pubmed-article:17091617pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17091617pubmed:citationSubsetIMlld:pubmed
pubmed-article:17091617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17091617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17091617pubmed:statusMEDLINElld:pubmed
pubmed-article:17091617pubmed:monthSeplld:pubmed
pubmed-article:17091617pubmed:issn0300-9009lld:pubmed
pubmed-article:17091617pubmed:authorpubmed-author:SantensPatric...lld:pubmed
pubmed-article:17091617pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:17091617pubmed:authorpubmed-author:Belgian...lld:pubmed
pubmed-article:17091617pubmed:issnTypePrintlld:pubmed
pubmed-article:17091617pubmed:volume106lld:pubmed
pubmed-article:17091617pubmed:ownerNLMlld:pubmed
pubmed-article:17091617pubmed:authorsCompleteYlld:pubmed
pubmed-article:17091617pubmed:pagination137-41lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:meshHeadingpubmed-meshheading:17091617...lld:pubmed
pubmed-article:17091617pubmed:year2006lld:pubmed
pubmed-article:17091617pubmed:articleTitleDetection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.lld:pubmed
pubmed-article:17091617pubmed:affiliationDept of Neurology, Gent University Hospital, Gent, Belgium. patrick.santens@ugent.belld:pubmed
pubmed-article:17091617pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17091617pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17091617pubmed:publicationTypeMulticenter Studylld:pubmed